The newest weight loss drug on the market, Zepbound, might also help keep people’s snoring down. On Wednesday, Eli Lilly announced the preliminary results of two Phase III trials testing its drug tirzepatide for people with both obesity and obstructive sleep apnea. Not only did those taking the drug lose much more…
from Gizmodo https://ift.tt/BNlhz0q
via IFTTT
